Delivering precise renal pathology and FDA and GDPR-compliant CRO services to help sponsors move kidney disease therapies forward.

At a glance

Years of experience

0

Annual biopsies

0

Dedicated employees

0

Behind every trial working toward better outcomes for kidney disease, precise pathology matters. That’s where we come in.

 

Our GCLP and GCP-trained staff, CAP, CLIA, HITRUST (e1), and New York State CLEP-certified laboratories, and advanced core research facilities enable us to partner with academic, pharmaceutical, and biotechnology institutions at all stages of research and development – from initial proof of concept through delivery of results.

Arkana Laboratories serves as a central biopsy processing lab for clinical trials, receiving more than 30,000 biopsies annually. Our team of 240+ employees is committed to the highest quality of clinicopathologic care, bringing unmatched concentration of renal pathology expertise to every study we support.

We partner with academic, pharmaceutical, and biotechnology institutions at every stage of R&D, and we do it through our FDA and GDPR-compliant CRO infrastructure with the security, discretion, and scientific rigor your program demands.

What Our Clinical Trials Division Offers

Our Clinical Trial Services

Arkana’s clinical trials division offers a comprehensive suite of services spanning pre-clinical trial and clinical trial phases. Below is an overview of our current service offerings by category.

Research Use Clinical Use
Board-Certified Pathologist Reads
Novel Biomarker Identification
Stains (Histochemical, Immunohistochemical, Enzymatic)
Transmission Electron Microscopy
qPCR (SNP, Copy Number, and Gene Expression)
NanoString Assays
APOL1 Genotyping
RNA/DNA Extraction (FFPE, Cells, Frozen Tissue)
Whole Slide Scanning
AI-based Quantitative Image Analysis
Multiplex Immunofluorescence Microscopy
Confocal Microscopy
Histopathologic Processing and Scoring of Tissue Sections
Biomarker Expression Analysis
Laser Capture Microdissection to Isolate Tissue Compartments
Investigation of Therapeutic Target Selection
Physician Clinical Trial Referral Services
Mass Spectrometry